BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11406044)

  • 1. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational therapy for patients with Parkinson's disease.
    Deane KH; Ellis-Hill C; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (3):CD002813. PubMed ID: 11687028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of physiotherapy techniques for patients with Parkinson's disease.
    Deane KH; Jones D; Ellis-Hill C; Clarke CE; Playford ED; Ben-Shlomo Y
    Cochrane Database Syst Rev; 2001; (1):CD002815. PubMed ID: 11279765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiotherapy for patients with Parkinson's Disease: a comparison of techniques.
    Deane KH; Jones D; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (3):CD002817. PubMed ID: 11687029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational therapy for patients with Parkinson's disease.
    Dixon L; Duncan D; Johnson P; Kirkby L; O'Connell H; Taylor H; Deane KH
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD002813. PubMed ID: 17636709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-pharmacological therapies for dysphagia in Parkinson's disease.
    Deane KH; Whurr R; Clarke CE; Playford ED; Ben-Shlomo Y
    Cochrane Database Syst Rev; 2001; 2001(1):CD002816. PubMed ID: 11279766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine in Parkinson's disease.
    Crosby N; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(1):CD003468. PubMed ID: 12535476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine for dyskinesia in Parkinson's disease.
    Crosby NJ; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(2):CD003467. PubMed ID: 12804468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker therapy for tremor in Parkinson's disease.
    Crosby NJ; Deane KH; Clarke CE
    Cochrane Database Syst Rev; 2003; 2003(1):CD003361. PubMed ID: 12535472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of paramedical therapies for Parkinson's disease.
    Deane KH; Ellis-Hill C; Jones D; Whurr R; Ben-Shlomo Y; Playford ED; Clarke CE
    Mov Disord; 2002 Sep; 17(5):984-91. PubMed ID: 12360547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and language therapy for dysarthria due to nonprogressive brain damage: a systematic Cochrane review.
    Sellars C; Hughes T; Langhorne P
    Clin Rehabil; 2002 Feb; 16(1):61-8. PubMed ID: 11837527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2001; (2):CD002088. PubMed ID: 11406032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2002; (4):CD002088. PubMed ID: 12519567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies for depression in Parkinson's disease.
    Shabnam GN; Th C; Kho D; H R; Ce C
    Cochrane Database Syst Rev; 2003; (3):CD003465. PubMed ID: 12917968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002088. PubMed ID: 16034872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergics for symptomatic management of Parkinson's disease.
    Katzenschlager R; Sampaio C; Costa J; Lees A
    Cochrane Database Syst Rev; 2003; 2002(2):CD003735. PubMed ID: 12804486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.